Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Conditions: Glabellar Lines Interventions: Biological: DWP712; Biological: BOTOX ® Sponsors: Daewoong Pharmaceutical Co. LTD. Recruiting

Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials